Chelsea Azevedo
Internal Medicine · Long Beach, CANPI 1881274900
Payments from drug & device makers
Across 49 payments — averaging $34.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$223
- AstraZeneca$172
- Bristol Myers Squibb$146
- Paratek Pharmaceuticals, Inc.$125
- Genentech USA, Inc.$113
- Johnson & Johnson$101
- plus $827 from 19 others
What the payments were for
- Food & beverage$1,45385%
- Education$25415%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 5 | $223 |
| AstraZeneca(2 entities) | 4 | $172 |
| Bristol Myers Squibb | 7 | $146 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Genentech USA, Inc. | 4 | $113 |
| Johnson & Johnson | 3 | $101 |
| Seagen Inc. | 1 | $100 |
| Lilly USA, LLC | 2 | $93 |
| AbbVie | 3 | $74 |
| Jazz Pharmaceuticals Inc. | 2 | $71 |
| Springworks Therapeutics, Inc. | 2 | $60 |
| Incyte Corporation | 2 | $54 |
| ADC Therapeutics America, Inc. | 1 | $33 |
| Pfizer | 1 | $32 |
| Menarini Silicon Biosystems, Inc. | 1 | $32 |
| Syndax Pharmaceuticals, Inc. | 1 | $32 |
| Gilead | 1 | $31 |
| Sanofi | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Deciphera Pharmaceuticals Inc. | 1 | $29 |
| Beigene USA, Inc. | 1 | $29 |
| Array Biopharma Inc | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Agios Pharmaceuticals, Inc. | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,707 in reported general payments places this provider in the 80th percentile of 13,581 internal medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 18 | $290 |
| Amlodipine Besylate | 15 | $140 |
| Lisinopril | 20 | $96 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Long Beach
- Mark LeibowitzLong Beach$7.6M
- Andrew ChengSouth San Francisco$55.1M
- Joel NeutelTustin$34.9M
- Donald BrandonSan Diego$34M
- William TownerLos Angeles$27.4M
- Rahul AggarwalSan Francisco$24M
- Masoud AzizadNorthridge$21.1M
- Helen StaceyWalnut Creek$20.4M
- Rohit Loombala Jolla$15.1M
- Zeid KayaliColton$14.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.